Richard A. Gonzalez's most recent trade in Abbvie Inc was a trade of 2,450 Common Stock, $0.01 par value done . Disclosure was reported to the exchange on March 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie | Richard A. Gonzalez | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Mar 2025 | 2,450 | 386,479 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director | Sale of securities on an exchange or to another person at price $ 205.11 per share. | 28 Feb 2025 | 92,460 | 395,097 (0%) | 0% | 205.1 | 18,964,471 | Common Stock, $0.01 par value |
| AbbVie | Richard A. Gonzalez | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.02 per share. | 28 Feb 2025 | 73,209 | 487,557 (0%) | 0% | 205.0 | 15,009,309 | Common Stock, $0.01 par value |
| AbbVie | Richard A. Gonzalez | Director | Sale of securities on an exchange or to another person at price $ 210.53 per share. | 28 Feb 2025 | 6,168 | 388,929 (0%) | 0% | 210.5 | 1,298,549 | Common Stock, $0.01 par value |
| AbbVie | Richard A. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 80,945 | 469,874 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 65,104 | 65,104 | - | - | Option (Right to Buy) | |
| AbbVie | Richard A. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 33,208 | 503,082 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 30,298 | 533,380 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 27,386 | 560,766 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 30 Sep 2024 | 36,698 | 388,929 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 30 Sep 2024 | 15,729 | 425,627 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 30 Sep 2024 | 5,243 | 441,356 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 05 Aug 2024 | 66,500 | 446,599 (0%) | 0% | 186.5 | 12,403,580 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 282,845 | 513,099 (0%) | 0% | 175 | 49,497,875 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 119,418 | 59,709 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 119,418 | 719,567 (0%) | 0% | 79.0 | 9,436,410 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 87,050 | 600,149 (0%) | 0% | 61.4 | 5,341,388 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 87,050 | 0 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 76,377 | 152,755 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 76,377 | 795,944 (0%) | 0% | 93.5 | 7,141,250 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 28 Jun 2024 | 6,000 | 513,099 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 28 Feb 2024 | 138,616 | 519,099 (0%) | 0% | 177.3 | 24,572,458 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 28 Feb 2024 | 110,249 | 657,715 (0%) | 0% | 179.0 | 19,733,469 | Common Stock, $0.01 par value | |
| AbbVie | Richard Gonzalez A. | Director, CHAIRMAN OF THE BOARD AND CEO | 27 Feb 2024 | 2,525 | 767,964 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | A. Richard Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 27 Feb 2024 | 1,670 | 770,489 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 15 Feb 2024 | 146,335 | 669,629 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | A. Richard Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 15 Feb 2024 | 113,472 | 113,472 | - | - | Option (Right to Buy) | ||
| AbbVie | Gonzalez A. Richard | Director, CHAIRMAN OF THE BOARD AND CEO | 15 Feb 2024 | 39,022 | 708,651 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | A. Richard Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 15 Feb 2024 | 33,208 | 741,859 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 15 Feb 2024 | 30,300 | 772,159 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 25 Sep 2023 | 42,000 | 523,294 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 31 Jul 2023 | 60,000 | 565,294 (0%) | 0% | 148.6 | 8,914,800 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 31 Jul 2023 | 18,500 | 625,294 (0%) | 0% | 149.2 | 2,759,275 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 03 Mar 2023 | 2,550 | 643,794 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 28 Feb 2023 | 113,810 | 646,344 (0%) | 0% | 154.3 | 17,558,607 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 16 Feb 2023 | 149,732 | 652,985 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 16 Feb 2023 | 114,787 | 114,787 | - | - | Option (Right to Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 16 Feb 2023 | 39,022 | 726,944 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 16 Feb 2023 | 34,937 | 687,922 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, CHAIRMAN OF THE BOARD AND CEO | 16 Feb 2023 | 33,210 | 760,154 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 25 Feb 2022 | 102,812 | 503,253 (0%) | 0% | 149.5 | 15,374,506 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 25 Feb 2022 | 2,610 | 606,065 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 17 Feb 2022 | 157,618 | 157,618 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 17 Feb 2022 | 133,889 | 510,486 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 17 Feb 2022 | 34,937 | 574,529 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 17 Feb 2022 | 34,146 | 608,675 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 17 Feb 2022 | 29,106 | 539,592 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Dec 2021 | 174,100 | 87,050 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Dec 2021 | 174,100 | 550,697 (0%) | 0% | 61.4 | 10,682,776 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Dec 2021 | 109,624 | 376,597 (0%) | 0% | 123.5 | 13,535,911 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Dec 2021 | 64,476 | 486,221 (0%) | 0% | 122.8 | 7,917,730 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 28 Feb 2021 | 170,113 | 0 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 28 Feb 2021 | 170,113 | 546,710 (0%) | 0% | 54.9 | 9,332,399 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 28 Feb 2021 | 169,482 | 377,228 (0%) | 0% | 108.6 | 18,407,220 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 28 Feb 2021 | 74,384 | 376,597 (0%) | 0% | 107.7 | 8,014,132 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 28 Feb 2021 | 3,325 | 450,981 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 28 Feb 2021 | 631 | 376,597 (0%) | 0% | 109.3 | 68,984 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 18 Feb 2021 | 192,546 | 192,546 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 18 Feb 2021 | 80,257 | 366,657 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 18 Feb 2021 | 34,938 | 454,306 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 18 Feb 2021 | 29,106 | 419,368 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 18 Feb 2021 | 23,605 | 390,262 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 23 Dec 2020 | 29,017 | 286,400 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 07 Dec 2020 | 3,225 | 315,417 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 177,983 | 334,813 (0%) | 0% | 97.1 | 17,275,297 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 109,097 | 0 | - | - | Option(Right to buy) | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 109,097 | 512,796 (0%) | 0% | 58.9 | 6,423,631 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 85,057 | 170,113 | - | - | Option(Right to buy) | ||
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 85,057 | 403,699 (0%) | 0% | 54.9 | 4,666,227 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 37,450 | 318,642 (0%) | 0% | 95.7 | 3,585,463 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, Chairman of the Board and CEO | 09 Nov 2020 | 16,171 | 318,642 (0%) | 0% | 97.5 | 1,576,493 | Common Stock, $0.01 par value |